Stranded by the Chop: Patients Losing Hope as Trump's Cuts Shackle Promising Cancer Therapy
Trump's aggressive approach to a promising cancer treatment is impeding its progress
** h3 {margin-bottom: 20px;} **
Social Media Sharing:- Facebook: Stranded by the Chop: Patients Losing Hope as Trump's Cuts Shackle Promising Cancer Therapy- Twitter: 🚨 Stranded by the Chop: Patients Losing Hope as Trump's Cuts Shackle Promising Cancer Therapy 🚨 publichealthcast #cancer #research #politics- Whatsapp: 🚨 Stranded by the Chop: Patients Losing Hope as Trump's Cuts Shackle Promising Cancer Therapy 🚨 Forward to friends and family! #cancer #research #politics #US- E-Mail: Tons of Progress in Cancer Research, but Trump's Cuts Are Putting the Brakes! 🚨 Stranded by the Chop: Patients Losing Hope as Trump's Cuts Shackle Promising Cancer Therapy 🚨 Check out this horrifying story! #cancer #research #politics- Print: Stranded by the Chop: Patients Losing Hope as Trump's Cuts Shackle Promising Cancer Treatments- Copy Link: https://publichealthcast.com/articles/stranded-by-the-chop- URL Shortener: https://bit.ly/3FAGxfu
** Contents **- The Trump Administration's Budget Cuts: A Recipe for Disaster- The National Institute of Health (NIH): The Lifeline of American Cancer Research- A Promising Cancer Therapy Stalls: Falling Off the Cliff- The Woe of the Cancer Champions: A Tough Blow for Trump Critics
The Trump Administration's Budget Cuts: A Recipe for Disaster
President Donald Trump, with his acolyte Elon Musk, is hacking into government spending like a barbarian at the gate. One of the first casualties of these reckless axe-wielding measures is the National Institute of Health (NIH), a bastion of world-leading medical research in the US. The Trump administration announced plans to slash funding and layoff hundreds of employees, threatening medical advancements and the lives of countless patients.
Economy Researchers On the Run: Could the US Be Bleeding Talent to Europe? NIH scientists have recently made a groundbreaking stride in the fight against cancer. Yet, on the same day that the breakthrough was published in "Nature Medicine", the NIH was hit by a devastating wave of layoffs. In the wake of budget cuts, research into promising cancer treatments is put on hold, and patients are left reeling.
The National Institute of Health (NIH): The Lifeline of American Cancer Research
Founded in 1887, the NIH provides approximately 8 billion USD annually for cancer research. It's the largest funder of cancer research in the US, working tirelessly to make leaps in prevention, diagnosis, and treatment. However, the recent budget cuts have forced the elimination of 1200 positions within the health ministry, jeopardizing years of progress and vital research.
A Promising Cancer Therapy Stalls: Falling Off the Cliff
Steven Rosenberg, a surgeon and cancer researcher at the National Cancer Institute (part of the NIH), is at the forefront of a new experimental cancer therapy. For years, scientists have been aiming to use the body's own immune cells to combat cancer. Using this approach, Rosenberg has achieved tumor shrinkage in about a quarter of patients with colon, rectal, and other gastrointestinal cancers. Although the therapy is still in its infancy, the onset of these drastic funding cuts have forced a crawl to a standstill in efforts to further refine and improve the therapy, potentially leaving patients high and dry.
The Woe of the Cancer Champions: A Tough Blow for Trump Critics
Natalie Phelps, a 43-year-old mother of two, is one such patient anxiously awaiting the development and implementation of this promising experimental treatment. In 2016, she was diagnosed with colon cancer, undergoing 18 hours of surgery, three liver operations, and 48 chemotherapy cycles to no avail. However, last year, she was offered the chance to participate in one of Rosenberg's clinical studies. Although hope is now within reach, her treatment has been delayed due to the financial influence of President Trump, wreaking havoc on her fragile health.
USAHealthChronicles of TrumpCancer
Enrichment Data: The funding cuts by the Trump administration have significantly impacted medical research, including cancer treatments, at the National Institutes of Health (NIH). Here are some key effects on the development and implementation of promising experimental cancer therapies:
Impacts of Funding Cuts
- NIH Grant Cancellations: Hundreds of NIH grants have been canceled, including those crucial for cancer research. This has delayed and disrupted ongoing projects, affecting the advancement of experimental treatments[2][5].
- Clinical Trial Disruptions: Clinical trials are vital for testing new cancer therapies. The funding cuts have led to cancellations and disruptions in these trials, impacting patients' access to experimental treatments[2].
- Research Slowing Down: The reduction in funding has caused researchers to focus on less risky projects to ensure continued productivity. This shift away from high-risk, high-reward projects may slow down breakthroughs in cancer therapy[3].
- Brain Drain: The uncertainty and instability in funding are causing concerns about retaining young scientists. A "brain drain" could potentially undermine long-term research capabilities in the U.S.[3][2].
- Universities' Response: Some universities are creating bridge programs to temporarily support researchers affected by the cuts. However, these programs are often insufficient to fully compensate for lost federal funding[1].
Effect on Experimental Cancer Therapies
The cuts have specifically impacted research into promising areas such as mRNA cancer vaccines, which are considered very promising but are now at risk of being disproportionately affected[3]. The delay in such research could lead to missed opportunities for developing effective treatments.
Overall, the funding cuts are not only delaying the development of new cancer therapies but also threaten the long-term sustainability of U.S. medical research leadership.
Source: ntv.de
Original Article by ntv.de Here
- The cutting of funding to the National Institute of Health (NIH) by the Trump Administration, as part of their budget cuts, has put research into promising employment opportunities related to cancer treatments on hold, frustrating researchers and patients alike.
- The economy could be adversely affected if the US loses talent in cancer research as a result of budget cuts, as scientists may be forced to seek employment in European agencies that haven't undergone similar funding reductions.
- Despite a breakthrough in a promising cancer treatment being published, hundreds of layoffs at the NIH due to the budget cuts have left patients hoping for this therapy feeling hopeless and anxious about its future development.
